Organogenesis Holding (ORGO) Prices 9M Share Common Offering at $5/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock
November 21, 2019 10:05 PM ESTCANTON, Mass., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced the pricing of an underwritten public offering of 9,000,000 shares of its Class A common stock, offered at a price to the public of $5.00 per share. The gross proceeds to Organogenesis Holdings from this offering are expected to be $45.0 million, before deducting the underwriting discounts and commissions and other offering expenses payable by Organogenesis Holdings.... More
Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock
November 21, 2019 10:04 PM ESTCANTON, Mass., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced the pricing of an underwritten public offering of 9,000,000 shares of its Class A common stock, offered at a price to the public of $5.00 per share. The gross proceeds to Organogenesis Holdings from this offering are expected to be $45.0 million, before deducting the underwriting discounts and commissions and other offering expenses payable by Organogenesis Holdings.... More
